✦ LIBER ✦

Mercury poisoning associated with high-dose hepatitis-B immune globulin administration after liver transplantation for chronic hepatitis B

✍ Scribed by Lowell, Jeffry A. ;Burgess, Sandy ;Shenoy, Surendra ;Curci, John A. ;Peters, Marion ;Howard, Todd K.

Publisher: Wiley (John Wiley & Sons)
Year: 1996
Tongue: English
Weight: 309 KB
Volume: 2
Category: Article
ISSN: 1074-3022
DOI: 10.1002/lt.500020612

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B virus with antigenically alt

Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation

✍ Ulrike Protzer-Knolle; Uta Naumann; Ralph Bartenschlager; Thomas Berg; Uwe Hopf; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

"Escape" variants of hepatitis B virus (HBV) can cause infection despite previous immunization. These viruses show alterations of the immunogenic major hydrophilic loop of the HBV small surface protein (s-protein). We studied whether HBV "escape" variants were selected in patients with graft infecti

Liver transplantation for chronic hepati

Liver transplantation for chronic hepatitis B infection with the use of combination lamivudine and low-dose hepatitis B immune globulin

✍ Yoshida, Eric M. ;Erb, Siegfried R. ;Partovi, Nilufar ;Scudamore, Charles H. ;Ch 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 71 KB 👁 1 views

Current protocols for prophylaxis against allograft reinfection after liver transplantation for chronic hepatitis B virus (HBV) infection include the administration of large doses of hepatitis B immune globulin (HBIG), with considerable associated economic costs. Monotherapeutic prophylaxis with lam

Intramuscular hepatitis B immune globuli

Intramuscular hepatitis B immune globulin combined with lamivudine for prophylaxis against hepatitis B recurrence after liver transplantation

✍ Yao, Francis Y. ;Osorio, Robert W. ;Roberts, John P. ;Poordad, Fred F. ;Briceno, 📂 Article 📅 1999 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 59 KB

Immunoprophylaxis using intravenous (IV) hepatitis B immune globulin (HBIG) decreases the recurrence of hepatitis B virus (HBV) infection after orthotopic liver transplantation (OLT). However, IV HBIG is expensive, has significant side effects, and is inconvenient to administer. An alternative appro

Hepatitis B virus–specific CD4 T cell im

Hepatitis B virus–specific CD4 T cell immunity after liver transplantation for chronic hepatitis B

✍ Ying Luo; Chung Mau Lo; Cindy K. Cheung; George K. Lau; John Wong 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 1 views

Cellular immunity plays an important role in the long-term control of hepatitis B virus (HBV) infection. We studied the changes in HBV-specific CD4 T cell immunity after orthotopic liver transplantation (OLT) for chronic hepatitis B under antiviral prophylaxis. T cell proliferation and interferon-␥

Protective antibody levels and dose requ

Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease

✍ Rolland C. Dickson; Norah A. Terrault; Michael Ishitani; K. Rajender Reddy; Patr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 185 KB 👁 1 views

Lamivudine combined with Hepatitis B immune globulin (HBIg) prevents post liver transplant (LT) HBV recurrence. The study was designed to assess the impact of lamivudine on hepatitis B antibody (anti-HBs) and dosage requirements of intravenous 5% HBIg (Nabi-HB) in the first 36 weeks post LT. Adults

Recurrence of hepatitis B is associated

Recurrence of hepatitis B is associated with cumulative corticosteroid dose and chemotherapy against hepatocellular carcinoma recurrence after liver transplantation

✍ Nam-Joon Yi; Kyung-Suk Suh; Jai Young Cho; Choon Hyuck Kwon; Kwang-Woong Lee; Ja 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

The incidence of hepatitis B (HB) recurrence after a liver transplantation has been reduced by prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine. However, the long-term incidence of recurrence is Ͻ10%, and the factors associated with HB recurrence are unclear. This study analyzed the